Anaemia during venetoclax ramp-up phase: Do not forget unusual causes

Int J Lab Hematol. 2022 Oct;44(5):e211-e214. doi: 10.1111/ijlh.13875. Epub 2022 May 11.

Authors

Chiara Adele Cavarretta¹, Andrea Visentin¹, Stefano Pravato¹, Elisa Piva², Francesco Piazza¹, Daniela Basso², Livio Trentin¹

Affiliations

¹ Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Italy.
² Laboratory Medicine, Department of Medicine, University of Padova, Padova, Italy.

PMID: 35538897
DOI: 10.1111/ijlh.13875

No abstract available

Publication types

Letter

MeSH terms

Anemia*
Antineoplastic Agents* / adverse effects
Antineoplastic Combined Chemotherapy Protocols
Bridged Bicyclo Compounds, Heterocyclic / adverse effects
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
Sulfonamides / adverse effects

Substances

Antineoplastic Agents
Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
venetoclax